Acute Bacterial Meningitis in Infants and Children

[1]  S. Pelton,et al.  A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children , 2011, Current opinion in pediatrics.

[2]  E. Bingen,et al.  PNEUMOCOCCAL MENINGITIS IN FRENCH CHILDREN BEFORE AND AFTER THE INTRODUCTION OF PNEUMOCOCCAL CONJUGATE VACCINE , 2011, The Pediatric infectious disease journal.

[3]  B. Muller-Pebody,et al.  Vancomycin may not be necessary , 2010, BMJ : British Medical Journal.

[4]  M. Mugglestone,et al.  Management of hypertensive disorders during pregnancy: summary of NICE guidance , 2010, BMJ : British Medical Journal.

[5]  M. S. Murphy,et al.  Management of bacterial meningitis and meningococcal septicaemia in children and young people: summary of NICE guidance , 2010, BMJ : British Medical Journal.

[6]  I. Rudan,et al.  Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. , 2010, The Lancet. Infectious diseases.

[7]  J. Lynch,et al.  Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines , 2010, Current opinion in pulmonary medicine.

[8]  T. Rodríguez-Blanco,et al.  Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older , 2010, BMC infectious diseases.

[9]  D. Granoff.  Review of meningococcal group B vaccines. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  L. Harrison.  Epidemiological profile of meningococcal disease in the United States. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  J. Farrar,et al.  Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data , 2011 .

[12]  S. Ladhani,et al.  Invasive Haemophilus influenzae Disease, Europe, 1996–2006 , 2010, Emerging infectious diseases.

[13]  K. Kim.  Acute bacterial meningitis in infants and children. , 2010, The Lancet. Infectious diseases.

[14]  W. Schaffner,et al.  Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. , 2010, The Journal of infectious diseases.

[15]  Robert H. Pratt,et al.  Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  M. Kruijshaar,et al.  Increase in extrapulmonary tuberculosis in England and Wales 1999–2006 , 2009, Thorax.

[17]  Gail M. Williams,et al.  Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age. , 2009, The Cochrane database of systematic reviews.

[18]  T. Cherian,et al.  Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates , 2009, The Lancet.

[19]  T. Cherian,et al.  Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates , 2009, The Lancet.

[20]  N. Chiu,et al.  National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential. , 2009, Vaccine.

[21]  A. Deghmane,et al.  Emerging drugs for acute bacterial meningitis , 2009, Expert opinion on emerging drugs.

[22]  E. Dasbach,et al.  Cost-effectiveness of pneumococcal polysaccharide vaccination in adults: a systematic review of conclusions and assumptions. , 2009, Vaccine.

[23]  M. Falagas,et al.  Short versus long duration of antibiotic therapy for bacterial meningitis: a meta-analysis of randomised controlled trials in children , 2009, Archives of Disease in Childhood.

[24]  R. Veenhoven,et al.  Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  E. Rosenqvist,et al.  Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. , 2009, Vaccine.

[26]  Lee H Harrison,et al.  Global epidemiology of meningococcal disease. , 2009, Vaccine.

[27]  R. Dagan,et al.  Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. , 2009, Vaccine.

[28]  H. Peltola,et al.  Improving the outcomes in children with bacterial meningitis , 2009, Current opinion in infectious diseases.

[29]  A. Bianco,et al.  Efficacy of Pneumococcal Vaccination in Children Younger Than 24 Months: A Meta-Analysis , 2009, Pediatrics.

[30]  I. Toth,et al.  Expression of maturation markers on murine dendritic cells in response to group A streptococcal lipopeptide vaccines. , 2009, Vaccine.

[31]  O. Levy,et al.  Developmental Biology of the Innate Immune Response: Implications for Neonatal and Infant Vaccine Development , 2009, Pediatric Research.

[32]  K. Sunakawa,et al.  Rapid detection of eight causative pathogens for the diagnosis of bacterial meningitis by real-time PCR , 2009, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[33]  T. Vesikari,et al.  Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the Licensed 7vCRM Vaccine , 2009, The Pediatric infectious disease journal.

[34]  P. Stehr-Green,et al.  Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years. , 2009, International journal of epidemiology.

[35]  J. Lynch,et al.  Streptococcus pneumoniae: Does Antimicrobial Resistance Matter? , 2009, Seminars in respiratory and critical care medicine.

[36]  J. Lynch,et al.  Streptococcus pneumoniae: Epidemiology, Risk Factors, and Strategies for Prevention , 2009, Seminars in respiratory and critical care medicine.

[37]  M. Moore.  Rethinking replacement and resistance. , 2009, The Journal of infectious diseases.

[38]  C. Whitney,et al.  PCR-Based Quantitation and Clonal Diversity of the Current Prevalent Invasive Serogroup 6 Pneumococcal Serotype, 6C, in the United States in 1999 and 2006 to 2007 , 2009, Journal of Clinical Microbiology.

[39]  P. Mcghee,et al.  Binding of Faropenem and Other β-Lactam Agents to Penicillin-Binding Proteins of Pneumococci with Various β-Lactam Susceptibilities , 2009, Antimicrobial Agents and Chemotherapy.

[40]  M. P. van der Linden,et al.  Association of Serotype of Streptococcus pneumoniae With Risk of Severe and Fatal Outcome , 2009, The Pediatric infectious disease journal.

[41]  A. Zaidi,et al.  Burden of Neonatal Infections in Developing Countries: A Review of Evidence From Community-Based Studies , 2009, The Pediatric infectious disease journal.

[42]  A. Zaidi,et al.  Pathogens Associated With Sepsis in Newborns and Young Infants in Developing Countries , 2009, The Pediatric infectious disease journal.

[43]  S. Schrag,et al.  Trends in perinatal group B streptococcal disease - United States, 2000-2006. , 2009, MMWR. Morbidity and mortality weekly report.

[44]  J. McVernon,et al.  Recommendations for the prevention of secondary Haemophilus influenzae type b (Hib) disease. , 2009, The Journal of infection.

[45]  R. Dagan,et al.  Impact of conjugate pneumococcal vaccines on antibiotic resistance. , 2008, The Lancet. Infectious diseases.

[46]  M. Edwards.  Group B streptococcal conjugate vaccine: A timely concept for which the time has come , 2008, Human vaccines.

[47]  K. O'Brien,et al.  Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[48]  A. Chaudhuri,et al.  EFNS guideline on the management of community‐acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults , 2008, European journal of neurology.

[49]  Y. F. Neelagund,et al.  Bacterial meningitis: rapid diagnosis and microbial profile: a multicentered study. , 2008, The Journal of communicable diseases.

[50]  S. Keam,et al.  Meropenem , 2012, Drugs.

[51]  S. Sarna,et al.  Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  D. Walker,et al.  Introduction of Hib vaccine into national immunization programmes: a descriptive analysis of global trends. , 2007, Vaccine.

[53]  R. Arnold,et al.  A prospective study of the effectiveness of the New Zealand meningococcal B vaccine. , 2007, American journal of epidemiology.

[54]  A. Pollard,et al.  Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines , 2007, Archives of Disease in Childhood.

[55]  Ronald N. Jones,et al.  Comparison of the probability of target attainment between ceftriaxone and cefepime in the cerebrospinal fluid and serum against Streptococcus pneumoniae. , 2007, Diagnostic microbiology and infectious disease.

[56]  A. Pollard,et al.  Reconsideration of the Use of Meningococcal Polysaccharide Vaccine , 2007, The Pediatric infectious disease journal.

[57]  B. Greenwood,et al.  Epidemic meningitis, meningococcaemia, and Neisseria meningitidis , 2007, The Lancet.

[58]  P. Aavitsland,et al.  Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease. , 2007, Vaccine.

[59]  M. Pichichero,et al.  Increased Antimicrobial Resistance Among Nonvaccine Serotypes of Streptococcus pneumoniae in the Pediatric Population After the Introduction of 7-Valent Pneumococcal Vaccine in the United States , 2007, The Pediatric infectious disease journal.

[60]  In Ho Park,et al.  Discovery of a New Capsular Serotype (6C) within Serogroup 6 of Streptococcus pneumoniae , 2007, Journal of Clinical Microbiology.

[61]  G. Barnaud,et al.  Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[62]  R. Boots,et al.  Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study. , 2006, The Journal of antimicrobial chemotherapy.

[63]  D. Stephens.  Conquering the meningococcus. , 2007, FEMS microbiology reviews.

[64]  F. Riordan,et al.  Bacterial Meningitis , 2007, CNS drugs.

[65]  J. Timsit,et al.  Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: The PNEUMOREA prospective multicenter study* , 2006, Critical care medicine.

[66]  Malcolm Guiver,et al.  Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit. , 2006, Journal of medical microbiology.

[67]  M. Kieny,et al.  A review of vaccine research and development: meningococcal disease. , 2006, Vaccine.

[68]  M. Brandileone,et al.  Increase in numbers of beta-lactam-resistant invasive Streptococcus pneumoniae in Brazil and the impact of conjugate vaccine coverage. , 2006, Journal of medical microbiology.

[69]  P. Pagliano,et al.  Combined treatment with ceftriaxone and linezolid of pneumococcal meningitis: a case series including penicillin-resistant strains. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[70]  J. Lau,et al.  Efficacy of Haemophilus influenzae type b vaccination of children: a meta-analysis , 2006, European Journal of Clinical Microbiology and Infectious Diseases.

[71]  L. Hagberg,et al.  Outcome of 8-hour dosing intervals with beta-lactam antibiotics in adult acute bacterial meningitis , 2006, Scandinavian journal of infectious diseases.

[72]  Tamara Pilishvili,et al.  Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. , 2005, JAMA.

[73]  T. Yurtseven,et al.  Rifampicin+ceftriaxone versus vancomycin+ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model. , 2005, International journal of antimicrobial agents.

[74]  R. Adegbola,et al.  Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study , 2005, The Lancet.

[75]  E. Eichenwald,et al.  Early-Onset Group B Streptococcal Disease in the Era of Maternal Screening , 2005, Pediatrics.

[76]  B. Toye,et al.  Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. , 2005, QJM : monthly journal of the Association of Physicians.

[77]  S. Obaro,et al.  Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial , 2005, The Lancet.

[78]  D. Feikin,et al.  Epidemiological differences among pneumococcal serotypes. , 2005, The Lancet. Infectious diseases.

[79]  members of the Eortc Genito-Urinary Tract Cancer Co-operat Group,et al.  Short course single daily ceftriaxone monotherapy for acute bacterial meningitis in children: Results of a Swiss multicenter study. Part II: Bacteriological results , 1990, Infection.

[80]  Allan R Tunkel,et al.  Practice guidelines for the management of bacterial meningitis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[81]  M. Swartz.  Bacterial meningitis--a view of the past 90 years. , 2004, The New England journal of medicine.

[82]  A. Stucki,et al.  Daptomycin Is Highly Efficacious against Penicillin-Resistant and Penicillin- and Quinolone-Resistant Pneumococci in Experimental Meningitis , 2004, Antimicrobial Agents and Chemotherapy.

[83]  A. Tunkel,et al.  Antimicrobial agents in the treatment of bacterial meningitis. , 2004, Infectious disease clinics of North America.

[84]  S. Madhi,et al.  Impact of Haemophilus influenzae Type b Conjugate Vaccine in South Africa and Argentina , 2004, The Pediatric infectious disease journal.

[85]  K. Ko,et al.  High Prevalence of Antimicrobial Resistance among Clinical Streptococcus pneumoniae Isolates in Asia (an ANSORP Study) , 2004, Antimicrobial Agents and Chemotherapy.

[86]  J. de Batlle,et al.  Neisseria meningitidis showing decreased susceptibility to ciprofloxacin: first report in Spain. , 2004, Journal of Antimicrobial Chemotherapy.

[87]  M. Jacobs,et al.  The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. , 2003, The Journal of antimicrobial chemotherapy.

[88]  A. Schuchat,et al.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. , 2003, The New England journal of medicine.

[89]  N. Andrews,et al.  Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis , 2003, BMJ : British Medical Journal.

[90]  G. Mccracken,et al.  Garenoxacin (BMS-284756) and Moxifloxacin in Experimental Meningitis Caused by Vancomycin-Tolerant Pneumococci , 2003, Antimicrobial Agents and Chemotherapy.

[91]  S. Buckingham,et al.  Pneumococcal Susceptibility to Meropenem in a Mid-South Children's Hospital , 2002, Southern medical journal.

[92]  M. Biros,et al.  Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center. , 2001, The Journal of emergency medicine.

[93]  K. Olsen,et al.  BMS-284756 in Experimental Cephalosporin-Resistant Pneumococcal Meningitis , 2001, Antimicrobial Agents and Chemotherapy.

[94]  C. Peckham,et al.  Meningitis in infancy in England and Wales: follow up at age 5 years , 2001, BMJ : British Medical Journal.

[95]  G. La Rosa,et al.  Rifampicin-resistant meningococci causing invasive disease: detection of point mutations in the rpoB gene and molecular characterization of the strains. , 2001, The Journal of antimicrobial chemotherapy.

[96]  Oleg O. Bilukha,et al.  Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2000, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[97]  Phil Barton,et al.  Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial , 2000, The Lancet.

[98]  T. Popović,et al.  Distribution of Neisseria meningitidisSerogroup B Serosubtypes and Serotypes Circulating in the United States , 2000, Journal of Clinical Microbiology.

[99]  J. Beyene,et al.  Predicting the outcome of neonatal bacterial meningitis. , 2000, Pediatrics.

[100]  C. Pai,et al.  Time-Kill Studies of Antimicrobial Combinations Including Cefotaxime, Ceftriaxone, Vancomycin and Meropenem against Cephalosporin-Resistant Streptococcus pneumoniae , 2000, Chemotherapy.

[101]  A. Gené,et al.  Neisseria meningitidis: evolution of penicillin resistance and phenotype in a children's hospital in Barcelona, Spain , 2000, Acta paediatrica.

[102]  J. Venter,et al.  Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. , 2000, Science.

[103]  R C George,et al.  Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis , 2000, BMJ : British Medical Journal.

[104]  M. Holodniy,et al.  Stability of Plasma Human Immunodeficiency Virus Load in VACUTAINER PPT Plasma Preparation Tubes during Overnight Shipment , 2000, Journal of Clinical Microbiology.

[105]  R. Borrow,et al.  Clinical features, laboratory findings and management of meningococcal meningitis in England and Wales: report of a 1997 survey. Meningococcal meningitis: 1997 survey report. , 2000, The Journal of infection.

[106]  J. McCullers,et al.  Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis. , 2000, The Journal of infectious diseases.

[107]  Brian G. Spratt,et al.  The Three Major Spanish Clones of Penicillin-Resistant Streptococcus pneumoniae Are the Most Common Clones Recovered in Recent Cases of Meningitis in Spain , 1999, Journal of Clinical Microbiology.

[108]  W. Craig,et al.  Pharmacokinetics and pharmacodynamics of antibiotics in meningitis. , 1999, Infectious disease clinics of North America.

[109]  G. Mccracken,et al.  Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group. , 1999, The Pediatric infectious disease journal.

[110]  D. Holt,et al.  Bacterial meningitis in the newborn: a prospective study of mortality and morbidity. , 1999, Seminars in perinatology.

[111]  C. Michelet,et al.  Trial of dexamethasone treatment for severe bacterial meningitis in adults , 1999, Intensive Care Medicine.

[112]  E. Anis,et al.  Effectiveness of a nationwide infant immunization program against Haemophilus influenzae b. The Israeli Pediatric Bacteremia and Meningitis Group. , 1999, Vaccine.

[113]  I. Jado,et al.  Evolution of Streptococcus pneumoniaeSerotypes and Antibiotic Resistance in Spain: Update (1990 to 1996) , 1998, Journal of Clinical Microbiology.

[114]  S. Kaplan,et al.  Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae. , 1998, Pediatrics.

[115]  G. Mccracken,et al.  Antibiotic pharmacodynamics in cerebrospinal fluid. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[116]  H. Jafri,et al.  Pharmacodynamics of Gatifloxacin in Cerebrospinal Fluid in Experimental Cephalosporin-Resistant Pneumococcal Meningitis , 1998, Antimicrobial Agents and Chemotherapy.

[117]  J. Wenger.  Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada. , 1998, The Pediatric infectious disease journal.

[118]  S. Jaffar,et al.  Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H. influenzae type b among Gambian children. , 1998, The Journal of infectious diseases.

[119]  J. Vázquez,et al.  Moderate resistance to penicillin in Neisseria meningitidis. , 1997, Microbiologia.

[120]  O. Nolte.  Rifampicin resistance in Neisseria meningitidis: evidence from a study of sibling strains, description of new mutations and notes on population genetics. , 1997, The Journal of antimicrobial chemotherapy.

[121]  I. Ofek,et al.  Phagocyte-Bacteria Interactions , 1997, Advances in dental research.

[122]  C. Cubells,et al.  Clinical data in children with meningococcal meningitis in a Spanish hospital , 1997 .

[123]  J. Vázquez,et al.  Moderate resistance to penicillin in Neisseria meningitidis : Frontiers in antimicrobial resistance , 1997 .

[124]  R N Grüneberg,et al.  Results of the Alexander Project: a continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens. , 1996, Diagnostic microbiology and infectious disease.

[125]  S. Kaplan,et al.  Consensus: management of infections in children caused by Streptococcus pneumoniae with decreased susceptibility to penicillin , 1995, The Pediatric infectious disease journal.

[126]  O. Ramilo,et al.  Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae , 1995, Antimicrobial agents and chemotherapy.

[127]  J. Bradley,et al.  Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis , 1995, Antimicrobial agents and chemotherapy.

[128]  M. Cetron,et al.  The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. , 1995, The New England journal of medicine.

[129]  C. Cabellos,et al.  Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. , 1995, The New England journal of medicine.

[130]  R. van Furth,et al.  High levels of interleukin 10 and tumor necrosis factor alpha in cerebrospinal fluid during the onset of bacterial meningitis. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[131]  G. Kanra,et al.  Beneficial effects of dexamethasone in children with pneumococcal meningitis. , 1995, The Pediatric infectious disease journal.

[132]  F. Baquero.  Pneumococcal Resistance to β-Lactam Antibiotics: A Global Geographic Overview , 1995 .

[133]  T. Pennington,et al.  Molecular characterization of rifampin-resistant Neisseria meningitidis , 1994, Antimicrobial Agents and Chemotherapy.

[134]  K. Olsen,et al.  Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis , 1994, Antimicrobial Agents and Chemotherapy.

[135]  S. Kaplan,et al.  Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins , 1994, Antimicrobial Agents and Chemotherapy.

[136]  C. John.  Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[137]  W. Buurman,et al.  Anti-CD14 antibodies reduce responses of cultured human endothelial cells to endotoxin. , 1993, Immunology.

[138]  K. Olsen,et al.  Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis , 1993, Antimicrobial Agents and Chemotherapy.

[139]  K. Einhäupl,et al.  Spectrum of complications during bacterial meningitis in adults. Results of a prospective clinical study. , 1993, Archives of neurology.

[140]  M. Osterholm,et al.  Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. , 1993, The Journal of pediatrics.

[141]  G. Mccracken,et al.  Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. , 1993, The Pediatric infectious disease journal.

[142]  O. Mokuolu,et al.  Chloramphenicol‐resistant Haemophilus influenzae meningitis in young urban Nigerian children , 1992, Acta paediatrica.

[143]  W. Scheld,et al.  Bacterial meningitis: pathogenesis, pathophysiology, and progress. , 1992, The New England journal of medicine.

[144]  P. Elsbach,et al.  Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. , 1992, The Journal of clinical investigation.

[145]  J. Kremastinou,et al.  Antibiotic sensitivities of Neisseria meningitidis isolates from patients and carriers in Greece , 1992, Epidemiology and Infection.

[146]  J. Ariza,et al.  Evaluation of vancomycin for therapy of adult pneumococcal meningitis , 1991, Antimicrobial Agents and Chemotherapy.

[147]  G. Palade,et al.  Ultrastructural localization of albumin transport across the cerebral microvasculature during experimental meningitis in the rat , 1991, The Journal of experimental medicine.

[148]  K. Olsen,et al.  The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. , 1991, The New England journal of medicine.

[149]  A. Tomasz,et al.  Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. , 1991, The Journal of infectious diseases.

[150]  P. Bonventre,et al.  Activation of in vitro proliferation of human T cells by a synthetic peptide of toxic shock syndrome toxin 1. , 1991, The Journal of infectious diseases.

[151]  A. Hightower,et al.  Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. , 1990, The Journal of infectious diseases.

[152]  O. Ramilo,et al.  Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation , 1990, The Journal of experimental medicine.

[153]  O. Ramilo,et al.  Molecular pathophysiology of bacterial meningitis: current concepts and therapeutic implications. , 1990, The Journal of pediatrics.

[154]  D. Jones,et al.  Meningococci with reduced susceptibility to penicillin , 1990, The Lancet.

[155]  K. Klugman.  Pneumococcal resistance to antibiotics , 1990, Clinical Microbiology Reviews.

[156]  F. Kayser,et al.  Einmal tägliche Ceftriaxon-Kurzzeittherapie der akuten bakteriellen Meningitis bei Kindern: Resultate einer Schweizerischen Multizenterstudie. Teil II: Bakteriologische Resultate , 1990 .

[157]  M. Radetsky.  Duration of treatment in bacterial meningitis: a historical inquiry , 1990, The Pediatric infectious disease journal.

[158]  Y. Sultan,et al.  Dexamethasone treatment for bacterial meningitis in children and adults , 1989, The Pediatric infectious disease journal.

[159]  P. Brandtzaeg,et al.  Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response , 1989, The Journal of experimental medicine.

[160]  E. Tuomanen,et al.  Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes , 1989, The Journal of experimental medicine.

[161]  S. Stewart,et al.  Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. , 1988, The New England journal of medicine.

[162]  J. Verhoef,et al.  Host defence to bacterial infection in the neonate. , 1988, The Journal of hospital infection.

[163]  C. Latorre,et al.  Neisseria meningitidis strains with decreased susceptibility to penicillin , 1987, The Pediatric infectious disease journal.

[164]  P. Small,et al.  Influence of body temperature on bacterial growth rates in experimental pneumococcal meningitis in rabbits , 1986, Infection and immunity.

[165]  W. Scheld,et al.  Morphologic alterations of the blood-brain barrier with experimental meningitis in the rat. Temporal sequence and role of encapsulation. , 1986, The Journal of clinical investigation.

[166]  P. Lambert,et al.  Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis. , 1982, The Journal of infectious diseases.

[167]  C. Lugowski,et al.  Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates. , 1981, Journal of immunology.

[168]  G. Mccracken,et al.  Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis. , 1981, The Journal of infectious diseases.

[169]  M. Sande,et al.  Cephalosporin antibiotics in therapy of experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis in rabbits. , 1978, The Journal of infectious diseases.

[170]  W. Feldman,et al.  Concentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis. , 1976, The Journal of pediatrics.

[171]  D. Hansman,et al.  A RESISTANT PNEUMOCOCCUS , 1967 .